Migraine Headaches
Neurology
3
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
2
Early DiscoveryClinical DevelopmentMarket
On Market (1)
Approved therapies currently available
U
RIMEGEPANTApproved
rimegepant
Unknown Companyoral
Competitive Landscape
3 companies ranked by most advanced pipeline stage
M&
Merck & Co.RAHWAY, NJ
1 programThe Utility of Telemedicine in the Management of MigraineN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
PfizerRimegepant
SK Life ScienceRWJ-333369
Merck & Co.The Utility of Telemedicine in the Management of Migraine
Clinical Trials (3)
Total enrollment: 145 patients across 3 trials
Acute Migraine Treatment in the ED With Gepants
Start: Jun 2025Est. completion: Oct 2026100 patients
Phase 4Recruiting
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
Start: Mar 2002Est. completion: Feb 2006
Phase 2Completed
The Utility of Telemedicine in the Management of Migraine
Start: Oct 2012Est. completion: Oct 201845 patients
N/ACompleted
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
11h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
11h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
12h ago
Director of Finance
CoMind
London, UK
12h ago
Electronics Engineering Manager
CoMind
London, UK
12h ago
Director of Information Technology
Zavation Medical Products
12h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 145 patients
3 companies competing in this space